Xtant Medical Holdings (XTNT) EV to EBIT (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported EV to EBIT for 16 consecutive years, with 39.8 the latest figure, recorded in Q4 2025.

• On a quarterly basis, EV to EBIT rose 235.33% year-over-year to 39.8 in Q4 2025; TTM through Dec 2025 was 8.74, a 290.72% increase from a year earlier, with the FY2025 full-year figure at 8.64, up 288.42% from the prior year.
• EV to EBIT was 39.8 for Q4 2025 at Xtant Medical Holdings, up from 31.57 in the prior quarter.
• Over five years, EV to EBIT peaked at 56.38 in Q1 2025 and troughed at 37197.24 in Q1 2021.
• A 5-year average of 1888.83 and a median of 29.39 in 2024 frame the typical range for EV to EBIT.
• Across the five-year window, EV to EBIT tumbled 901905.69% in 2021 and soared 237.57% in 2025, its largest moves.
• Over 5 years, EV to EBIT stood at 15.89 in 2021, then tumbled by 87.41% to 29.79 in 2022, then dropped by 24.54% to 37.09 in 2023, then grew by 20.71% to 29.41 in 2024, then soared by 235.33% to 39.8 in 2025.
• The last three EV to EBIT figures came in at 39.8 (Q4 2025), 31.57 (Q3 2025), and 20.72 (Q2 2025), per Business Quant data.